The fungus recovers some of the energy it spent making light
In the quiet chemistry of glowing fungi, scientists have long glimpsed a lantern they could not yet fully hold. A research team at the University of São Paulo has now mapped the final piece of that mechanism — an enzyme called CPH that recycles the spent byproducts of light emission back into usable fuel, closing a biological loop that sustains luminescence without exhausting the organism. Published in The FEBS Journal, this eight-year culmination transforms a forest curiosity into an engineering blueprint, one with implications for how we image disease, monitor ecosystems, and read the living world by its own light.
- For decades, bioluminescent fungi offered medicine a tantalizing promise — real-time visualization of tumors and inflammation — but the pathway's inefficiency kept that promise just out of reach.
- The identification of CPH's role resolves a long-standing gap: this enzyme breaks oxyluciferin into caffeic acid and pyruvic acid, completing a recycling loop that lets fungi glow without burning through their own energy reserves.
- The discovery arrives with a practical tool attached — a new method to monitor CPH activity directly, giving the broader research community a way to probe bioluminescent systems with new precision.
- Engineered cells designed around this recycling mechanism could emit brighter, more sustained light, opening pathways for tumor tracking, inflammatory imaging, crop health monitoring, and environmental pollution detection.
- The field is shifting from borrowing nature's effects to understanding nature's logic — and that shift is what turns a biological phenomenon into a scalable biotechnology.
Certain fungi glow in the dark through their own evolved machinery — specialized enzymes converting chemical energy into visible light. Medical researchers have long recognized the potential: bioluminescent systems that could track tumors in real time or map how inflammation moves through tissue. The obstacle was always understanding how these systems sustain themselves, and whether they could be made to run brighter and longer without draining cellular energy.
A research team has now answered that question. Their study, published in The FEBS Journal, focused on an enzyme called caffeylpyruvate hydrolase — CPH — the final step in the fungal bioluminescence pathway. The work confirms that CPH breaks down oxyluciferin, the compound produced during light emission, into caffeic acid and pyruvic acid. The caffeic acid loops back into the light-producing pathway as reusable fuel; the pyruvic acid feeds into the cell's central energy metabolism. The fungus, in effect, recovers part of what it spent.
Cassius V. Stevani of the University of São Paulo described the confirmation as the culmination of eight years of work. The team also developed a new method to monitor CPH activity, giving other researchers a tool to study bioluminescence with greater depth and precision.
The implications extend well beyond the laboratory bench. Understanding how fungi sustain their own light emission makes it possible to engineer other organisms — lab-grown cells, for instance — to do the same, more efficiently and more brightly. In medicine, that means sharper imaging of tumors and inflammatory responses. In agriculture, bioluminescent organisms could monitor crop health or signal the presence of pathogens. In environmental science, they could track pollution or ecosystem shifts. What was once a curiosity from the forest floor is becoming, piece by piece, a blueprint for an entirely new class of biotechnology.
Certain fungi glow in the dark much like fireflies or the creatures of the deep ocean—not through any trick of chemistry we invented, but through their own evolved machinery. Specialized enzymes inside these organisms convert chemical energy into visible light, a process called bioluminescence. For years, medical researchers have recognized the potential: if you could harness these fungal light-producing systems, you could watch tumors grow in real time, or track how inflammation spreads through tissue. The challenge has always been understanding exactly how these systems work, and whether they could be made to run longer and brighter without burning through cellular energy like a candle.
A research team working with one of nature's brightest bioluminescent fungi has now solved a critical piece of that puzzle. Their work, published in The FEBS Journal, focused on an enzyme called caffeylpyruvate hydrolase—CPH for short—the final enzyme in the fungal bioluminescence pathway. For years, scientists suspected CPH played a role in recycling the byproducts of light emission, but the evidence remained murky. This new study confirms what researchers had theorized: CPH breaks down oxyluciferin, the glowing compound produced during bioluminescence, into two simpler molecules: caffeic acid and pyruvic acid.
What makes this discovery elegant is what happens next. The caffeic acid loops back into the light-producing pathway, allowing the fungus to keep glowing without constantly manufacturing new fuel from scratch. The pyruvic acid, meanwhile, gets redirected into the cell's central metabolism—the machinery that generates energy. In other words, the fungus recovers some of the energy it spent making light in the first place. It's a closed loop, a system that sustains itself more efficiently than anyone had fully understood before.
Cassius V. Stevani, a co-corresponding author of the study from the University of São Paulo, described the moment of confirmation as the culmination of eight years of work. The team had finally demonstrated the complete recycling mechanism, showing how fungi manage to keep their bioluminescence running without exhausting themselves. They also developed a new method to monitor CPH activity itself, creating a tool that other researchers can now use to study bioluminescence in greater depth.
The implications ripple outward quickly. If you understand how fungi sustain their own light emission, you can begin to engineer other organisms—cells grown in the lab, perhaps—to emit light in the same way. Brighter light. More efficient light. Light that doesn't demand constant energy input. In medicine, this means better imaging of tumors and inflammatory responses. But the applications extend far beyond the clinic. Agricultural researchers could use bioluminescent organisms to monitor crop health or detect pathogens. Environmental scientists could deploy them to track pollution or ecosystem changes. Biotechnology companies could build entirely new tools powered by these natural light-producing pathways.
The work represents a shift from simply borrowing nature's tricks to actually understanding the engineering principles underneath them. Once you know how the system works—how it recycles, how it conserves energy, how it sustains itself—you can begin to redesign it. The fungal bioluminescence pathway is no longer just a curiosity from the forest floor. It's becoming a blueprint.
Notable Quotes
The breakdown of fungal oxyluciferin by CPH produces caffeic acid and pyruvic acid, explaining how fungi sustain bioluminescence through metabolite recycling while recovering part of the energy invested in light emission.— Cassius V. Stevani, PhD, University of São Paulo, Brazil
The Hearth Conversation Another angle on the story
Why does it matter that we understand how fungi recycle their own light-producing byproducts?
Because efficiency changes everything. If a bioluminescent system wastes energy, it burns out fast. But if it recycles—if it recovers some of the energy it spent—then you can keep it running longer and brighter. That's the difference between a tool that works for minutes and one that works for hours.
So this isn't just about fungi glowing. It's about designing cells that glow on demand.
Exactly. Once you understand the mechanism, you can transplant it. You can take this pathway and put it into other organisms, engineer them to emit light more efficiently than nature ever did on its own.
What would a surgeon do with a tumor that glows?
See it in real time. Watch where it spreads. Know exactly what you're cutting out. Right now, surgeons often work with imperfect information. Bioluminescence could change that.
And this works in living tissue?
That's the next frontier. The lab work is solid. The real test is whether these systems can function inside the body, in the noise and complexity of actual human tissue.
How long until we see this in a hospital?
The science is moving fast, but medical translation always takes time. Years, probably. But the foundation is there now. This study closed a gap that's been open for nearly a decade.